Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
doi 10.1001/archinte.160.19.2998
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Inducible COX-2 Dominates Over COX-1 in Prostacyclin Biosynthesis: Mechanisms of COX-2 Inhibitor Risk to Heart Disease

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2011English

COX-1 and COX-2 in Health and Disease

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

Editorial: Gastrointestinal Safety of COX-2 Selective and Nonselective NSAIDs-the Impact of the PRECISION Trial

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Role of the Selective Cyclo-Oxygenase-2 (COX-2) Inhibitors in Children

Archives of Disease in Childhood: Education and Practice Edition
Child HealthPediatricsPerinatology
2004English

Arachidonic Acid Oxygenation by COX-1 and COX-2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Scaffold of the Cyclooxygenase-2 (COX-2) Inhibitor Carprofen Provides Alzheimer G-Secretase Modulators

English

Cox-2 Specific Inhibitors (Coxibs) Crisis

Basrah Journal of Surgery
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy